Top

Published in:

28-07-2023 | Spina Bifida | Review

Multidisciplinary management of people with spina bifida across the lifespan

Authors: Vera H. Koch, MarcosTomasin Lopes, Erika Furusawa, Katharinne Vaz, Ubirajara Barroso

Published in: Pediatric Nephrology | Issue 3/2024

Abstract

The average worldwide prevalence of neural tube defects (NTDs) is 1.0 per 1000 births. Its development is multifactorial due to genetic and non-genetic factors. Spina bifida (SB) is one of main representatives of NTD. The spinal cord lesion level is the main determinant of the level of paralysis, numbness, and difficulties with bladder/bowel functions. Myelomeningocele prenatal repair reduces hydrocephalus and hindbrain herniation and improves motor function. The severity of hydrocephalus is associated with poorer neurodevelopmental outcomes whether operated on prenatally or after birth. People with SB tend to have a lower IQ and cognitive difficulties. Early diagnosis, proactivity, and lifelong multidisciplinary follow-up are key protective issues. Invasive urological interventions should be considered in selected patients after failure of conservative treatment. Transition to adult care should be well planned as it is challenging. Health literacy is directly associated with success at transition. Sexuality and fertility should be addressed before/during puberty. Overall, the rates of fecal and urinary continence and skin breakdown increase with age, whereas the ability to ambulate declines with age. Bowel and urinary incontinence are independent predictors of lower health-related quality of life (HRQoL) in adults with SB. Bowel incontinence has negative impact on HRQoL regardless of frequency or amount. Long-term caregiver support should be offered at diagnosis. Survival at a mean of 50 years is poor, at 32%, due to central nervous system deaths, cancer, urological disease, and sepsis. Challenges to implementation of recommended practices exist, especially in low and middle-income countries.

Catala M (2021) Overview of secondary neurulation. J Korean Neurosurg Soc 64:346–358. https://doi.org/10.3340/jkns.2020.0362CrossRefPubMedPubMedCentral

Au KS, Ashley-Koch A, Northrup H (2010) Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev 16:6–15. https://doi.org/10.1002/ddrr.93CrossRefPubMedPubMedCentral

Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM (2015) Spina bifida. Nat Rev Dis Primers 1:15007. https://doi.org/10.1038/nrdp.2015.7CrossRefPubMedPubMedCentral

Cornette L, Verpoorten C, Lagae L, Plets C, Van Calenbergh F, Casaer P (1998) Closed spinal dysraphism: a review on diagnosis and treatment in infancy. Eur J Paediatr Neurol 2:179–185. https://doi.org/10.1016/s1090-3798(98)80017-2CrossRefPubMed

Tortori-Donati P, Rossi A, Cama A (2000) Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology 42:471–491. https://doi.org/10.1007/s002340000325CrossRefPubMed

International Center on Birth Defects. International Clearinghouse for Birth Defects Monitoring Systems (ICBDMS), Annual Report 2011 with Data for 2009. https://ghdx.healthdata.org/record/international-clearinghouse-birth-defects-surveillance-and-research-annual-report-2011. Accessed 8 June 2023

Li Z, Ren A, Zhang L, Ye R, Li S, Zheng J, Hong S, Wang T, Li Z (2006) Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol 76:237–240. https://doi.org/10.1002/bdra.20248CrossRefPubMed

Padmanabhan R (2006) Etiology, pathogenesis, and prevention of neural tube defects. Congenit Anom (Kyoto) 46:55–67. https://doi.org/10.1111/j.1741-4520.2006.00104.xCrossRefPubMed

Shaw GM, Velie EM, Wasserman CR (1997) Risk for neural tube defect- affected pregnancies among women of Mexican descent and white women in California. Am J Public Health 87:1467–1471. https://doi.org/10.2105/ajph.87.9.1467CrossRefPubMedPubMedCentral

10.

Kennedy D, Chitayat D, Winsor EJ, Silver M, Toi A (1998) Prenatally diagnosed neural tube defects: ultrasound, chromosome, and autopsy or postnatal findings in 212 cases. Am J Med Genet 77:317–321. https://doi.org/10.1002/(sici)1096-8628(19980526)77:4%3c317::aid-ajmg13%3e3.0.co;2-lCrossRefPubMed

11.

Avagliano L, Massa V, George TM, Qureshy S, Bulfamante GP, Finnell RH (2019) Overview on neural tube defects: from development to physical characteristics. Birth Defects Res 1111:1455–1467. https://doi.org/10.1002/bdr2.1380CrossRef

12.

Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832–1835CrossRefPubMed

13.

MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131–137CrossRef

14.

Centers for Disease Control and Prevention (CDC) (2009) Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995–2005. MMWR Morb Mortal Wkly Rep 57:1409–1413. Erratum in: MMWR Morb Mortal Wkly Rep 58:61

15.

Harris MJ, Juriloff DM (2010) An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol 88:653–669. https://doi.org/10.1002/bdra.20676CrossRefPubMed

16.

Lindquist B, Jacobsson H, Strinnholm M, Peny-Dahlstrand M (2022) A scoping review of cognition in spina bifida and its consequences for activity and participation throughout life. Acta Paediatr 111:1682–1694. https://doi.org/10.1111/apa.16420CrossRefPubMedPubMedCentral

17.

Houtrow AJ, MacPherson C, Jackson-Coty J, Rivera M, Flynn L, Burrows PK, Adzick NS, Fletcher J, Gupta N, Howell LJ, Brock JW 3rd, Lee H, Walker WO, Thom EA (2021) Prenatal repair and physical functioning among children with myelomeningocele: a secondary analysis of a randomized clinical trial. JAMA Pediatr 175:e205674. https://doi.org/10.1001/jamapediatrics.2020.5674CrossRefPubMedPubMedCentral

18.

Chen F, Gerhardt J, Entezami M, Chaoui R, Henrich W (2015) Detection of spina bifida by first trimester screening – results of the prospective multicenter Berlin IT study. Ultraschall Med 38:151–157. https://doi.org/10.1055/s-0034-1399483CrossRefPubMed

19.

Mace P, Mancini J, Gorincour G, Quarello E (2020) Accuracy of qualitative and quantitative cranial ultrasonographic markers in first trimester screening for open spina bifida and other posterior brain defects: a systematic review and meta-analysis. BJOG 128:354–365. https://doi.org/10.1111/1471-0528.16530CrossRefPubMed

20.

Sepulveda W, Wong AE, Sepulveda F, Alcalde JL, Devoto JC, Otayza F (2017) Prenatal diagnosis of spina bifida: from intracranial translucency to intrauterine surgery. Childs Nerv Syst 33:1083–1099. https://doi.org/10.1007/s00381-017-3445-7CrossRefPubMed

21.

Macé P, Ben Miled S, Corroënne R, James S, Stirnemann J (2021) Évaluation pronostique prénatale échographique de la myéloméningocèle à l’ère de la chirurgie fœtale [Prenatal ultrasound prognostic of myelomeningocele at the era of fetal surgery]. Gynecol Obstet Fertil Senol 49:617–629. https://doi.org/10.1016/j.gofs.2021.05.003CrossRefPubMed

22.

Adzick NS (2012) Fetal surgery for myelomeningocele: trials and tribulations. Isabella Forshall Lecture. J Pediatr Surg 47:273–281. https://doi.org/10.1016/j.jpedsurg.2011.11.021CrossRefPubMedPubMedCentral

23.

Adzick NS, Sutton LN, Crombleholme TM, Flake AW (1998) Successful fetal surgery for spina bifida. Lancet 352:1675–1676. https://doi.org/10.1016/S0140-6736(98)00070-1CrossRefPubMed

24.

Tulipan N, Hernanz-Schulman M, Bruner JP (1998) Reduced hindbrain herniation after intrauterine myelomeningocele repair: a report of four cases. Pediatr Neurosurg 29:274–278. https://doi.org/10.1159/000028735CrossRefPubMed

25.

Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D’Alton ME, Farmer DL, MOMS Investigators (2011) A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:993–1004. https://doi.org/10.1056/NEJMoa1014379CrossRefPubMedPubMedCentral

26.

Verweij EJ, de Vries MC, Oldekamp EJ, Eggink AJ, Oepkes D, Slaghekke F, Spoor JKH, Deprest JA, Miller JL, Baschat AA, DeKoninck PLJ (2021) Fetoscopic myelomeningocoele closure: is the scientific evidence enough to challenge the gold standard for prenatal surgery? Prenat Diagn 41:949–956. https://doi.org/10.1002/pd.5940CrossRefPubMedPubMedCentral

27.

Gerber JA, Stocks BT, Zhu H, Castillo H, Castillo J, Borden AN, Tu DD, Whitehead WE, Austin PF (2021) Prevalence of high-risk bladder categorization with prenatal and postnatal myelomeningocele repair types. Neurourol Urodyn 40:829–839. https://doi.org/10.1002/nau.24629CrossRefPubMed

28.

Snow-Lisy DC, Yerkes EB, Cheng EY (2015) Update on urological management of spina bifida from prenatal diagnosis to adulthood. J Urol 194:288–296. https://doi.org/10.1016/j.juro.2015.03.107CrossRefPubMed

29.

Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJM, Quadackers JSLT, Rawashdeh YF, Silay MS, Tekgul S, Radmayr C (2020) EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment. Neurourol Urodyn 39:45–57. https://doi.org/10.1002/nau.24211CrossRefPubMed

30.

Klose AG, Sackett CK, Mesrobian HG (1990) Management of children with myelodysplasia: urological alternatives. J Urol 144:1446–1449. https://doi.org/10.1016/s00225347(17)39763-xCrossRefPubMed

31.

Kaufman AM, Ritchey ML, Roberts AC, Rudy DC, McGuire EJ (1996) Decreased bladder compliance in patients with myelomeningocele treated with radiological observation. J Urol 156:2031–2033CrossRefPubMed

32.

Teichman JM, Scherz HC, Kim KD, Cho DH, Packer MG, Kaplan GW (1994) An alternative approach to myelodysplasia management: aggressive observation and prompt intervention. J Urol 152:807–811. https://doi.org/10.1016/s0022-5347(17)32716-7CrossRefPubMed

33.

Hopps CV, Kropp KA (2003) Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close follow up. J Urol 169:305–308. https://doi.org/10.1097/01.ju.0000040590.35948.bcCrossRefPubMed

34.

Geraniotis E, Koff SA, Enrile B (1988) The prophylactic use of clean intermittent catheterization in the treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction. J Urol 139:85–86. https://doi.org/10.1016/s00225347(17)42300-744CrossRefPubMed

35.

Kasabian NG, Bauer SB, Dyro FM, Colodny AH, Mandell J, Retik AB (1992) The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 146:840–843. https://doi.org/10.1001/archpedi.1992.02160190072024CrossRefPubMed

36.

Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, de Jong TP (2006) Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 49:908-913.https://doi.org/10.1016/j.eururo.2005.12.056

37.

Edelstein RA, Bauer SB, Kelly MD, Darbey MM, Peters CA, Atala A, Mandell J, Colodny AH, Retik AB (1995) The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 154:1500–1504CrossRefPubMed

38.

Wu HY, Baskin LS, Kogan BA (1997) Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol 157:2295–2297CrossRefPubMed

39.

Kaye IY, Payan M, Vemulakonda VM (2016) Association between clean intermittent catheterization and urinary tract infection in infants and toddlers with spina bifida. J Pediatr Urol 12:284.e1-284.e6. https://doi.org/10.1016/j.jpurol.2016.02.010CrossRefPubMed

40.

Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB (1999) Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol 162:1068–1071. https://doi.org/10.1097/00005392199909000-00031CrossRefPubMed

41.

Yadav P, Alsabban A, de Los RT, Varghese A, Ming JM, Milford K, Yang SS, Silangcruz JM, Dos Santos J, Bagli DJ, Rickard M, Lorenzo AJ, Church P, Chua ME (2022) A systematic review of paediatric neurogenic lower urinary tract dysfunction guidelines using the Appraisal of Guidelines and Research Evaluation (AGREE) II instrument. BJU Int 131:520–529. https://doi.org/10.1111/bju.15902CrossRefPubMed

42.

Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease [Internet]. London: Royal College of Physicians (UK); 2012.National Institute for Health and Clinical Excellence: Guidance). Available from: http://www.ncbi.nlm.nih.gov/books/NBK132831/ Accessed 2/21/23

43.

Joseph DB, Baum MA, Tanaka ST, Frimberger DC, Misseri R, Khavari R, Baillie S, Yerkes EB, Wood H (2020) Urologic guidelines for the care and management of people with spina bifida. J Pediatr Rehabil Med 13:479–489. https://doi.org/10.3233//PRM-200712CrossRefPubMedPubMedCentral

44.

Governey S, Culligan E, Leonard J (2014) The health and therapy needs of children with spina bifida in Ireland [Internet]. Available from: https://www.cuh.ie/wpcontent/uploads/2015/07/SB-Research.pdf Accessed 2/21/2023

45.

Routh JC, Cheng EY, Austin JC, Baum MA, Gargollo PC, Grady RW, Herron AR, Kim SS, King SJ, Koh CJ, Paramsothy P, Raman L, Schechter MS, Smith KA, Tanaka ST, Thibadeau JK, Walker WO, Wallis MC, Wiener JS, Joseph DB (2016) Design and methodological considerations of the centers for disease control and prevention urologic and renal protocol for the newborn and young child with spina bifida. J Urol 196:1728–1734. https://doi.org/10.1016/j.juro.2016.07.081CrossRefPubMedPubMedCentral

46.

Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJM, Quaedackers J, Rawashdeh YF, Silay MS, Tekgul S, Radmayr C (2020) EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management. Neurourol Urodyn 39:498–506CrossRefPubMed

47.

Bauer SB, Austin PF, Rawashdeh YF, De Jong TP, Franco I, Siggard C, Jorgensen TM, International Children’s Continence Society (2012) International Children’s Continence Society’s recommendations for initial diagnostic evaluation and follow-up in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn 31:610–614. https://doi.org/10.1002/nau.22247CrossRefPubMed

48.

Rawashdeh YF, Austin P, Siggaard C, Bauer SB, Franco I, de Jong TP, Jorgensen TM (2012) International Children’s Continence Society. International Children’s Continence Society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn 31:615–620. https://doi.org/10.1002/nau.22248CrossRefPubMed

49.

Sager C, Barroso U Jr, Netto BJM, Retamal G, Ormaechea E (2022) Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment. Int Braz J Urol 48:31–51. https://doi.org/10.1590/S1677-5538.IBJU.2020.098CrossRefPubMed

50.

Jaggi A, Drake M, Siddiqui E, Nazir J, Giagos V, Fatoye F (2018) A critical appraisal of the principal guidelines for neurogenic lower urinary tract dysfunction using the AGREE II instrument. Neurourol Urodyn 37:2945–2950. https://doi.org/10.1002/nau.23775CrossRefPubMed

51.

Zhao C, Hu Y, Wang X, Hao F, Wang Y, Chen L, Cai WZ (2022) Clinical practice guidelines for the management of adult patients with neurogenic lower urinary tract dysfunction: a systematic review protocol. BMJ Open 12:e064978. https://doi.org/10.1136/bmjopen-2022-064978CrossRefPubMedPubMedCentral

52.

Kim WJ, Shiroyanagi Y, Yamazaki Y (2015) Can bladder wall thickness predict videourodynamic findings in children with spina bifida? J Urol 194:180–183. https://doi.org/10.1016/j.juro.2015.03.002CrossRefPubMed

53.

Tanaka H, Matsuda M, Moriya K, Mitsui T, Kitta T, Nonomura K (2008) Ultrasonographic measurement of bladder wall thickness as a risk factor for upper urinary tract deterioration in children with myelodysplasia. J Urol 180:312–316. https://doi.org/10.1016/j.juro.2008.03.062CrossRefPubMed

54.

Arora G, Narasimhan KL, Saxena AK, Kaur B, Mittal BR (2007) Risk factors for renal injury in patients with meningomyelocele. Indian Pediatr 44:417–420PubMed

55.

Stoneking BJ, Brock JW, Pope JC, Adams MC (2001) Early evolution of bladder emptying after myelomeningocele closure. Urology 58:767–771. https://doi.org/10.1016/s00904295(01)01367-xCrossRefPubMed

56.

Bauer SB, Nijman RJ, Drzewiecki BA, Sillen U, Hoebeke P, International Children’s Continence Society Standardization Subcommittee (2015) International Children’s Continence Society standardization report on urodynamic studies of the lower urinary tract in children. Neurourol Urodyn 34:640–647. https://doi.org/10.1002/nau.22783CrossRefPubMed

57.

McGuire EJ, Woodside JR, Borden TA, Weiss RM (1981) Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 126:205–209. https://doi.org/10.1016/s0022-5347(17)54449-3CrossRefPubMed

58.

McGuire EJ, Woodside JR, Borden TA (1983) Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a follow up study. J Urol 129:823–826. https://doi.org/10.1016/s0022-5347(17)52384-8CrossRefPubMed

59.

Filler G, Gharib M, Casier S, Lödige P, Ehrich JH, Dave S (2012) Prevention of chronic kidney disease in spina bifida. Int Urol Nephrol 44:817–827. https://doi.org/10.1007/s11255-010-9894-5CrossRefPubMed

60.

Tanaka ST, Paramsothy P, Thibadeau J, Wiener JS, Joseph DB, Cheng EY, Tu D, Austin C, Koh CJ, Wallis MC, Walker WO, Smith KA, Routh JC, Baum MA (2019) Baseline urinary tract imaging in infants enrolled in the UMPIRE protocol for children with spina bifida. J Urol 201:1193–1198. https://doi.org/10.1097/JU.0000000000000141CrossRefPubMedPubMedCentral

61.

Tanaka ST, Yerkes EB, Routh JC, Tu DD, Austin JC, Wiener JS, Vasquez E, Joseph DB, AhnJJ WMC, Williams T, Rose C, Baum MA, Cheng EY (2021) Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: findings from the UMPIRE multicenter study. J Pediatr Urol 17:726–732. https://doi.org/10.1016/j.jpurol.2021.04.019CrossRefPubMed

62.

Quan A, Adams R, Ekmark E, Baum M (1997) Serum creatinine is a poor marker of glomerular filtration rate in patients with spina bifida. Dev Med Child Neurol 39:808–810. https://doi.org/10.1111/j.1469-8749.1997.tb07547CrossRefPubMed

63.

Ozel SK, Dokumcu Z, Akyildiz C, Avanoglu A, Ulman I (2007) Factors affecting renal scar development in children with spina bifida. Urol Int 79:133–136. https://doi.org/10.1159/000106326CrossRefPubMed

64.

Lorenzo AJ, Rickard M, Santos JD (2020) The role of bladder function in the pathogenesis and treatment of urinary tract infections in toilet-trained children. Pediatr Nephrol 35:1395–1408. https://doi.org/10.1007/s00467-019-4193-6CrossRefPubMed

65.

Olandoski KP, Koch V, Trigo-Rocha FE (2011) Renal function in children with congenital neurogenic bladder. Clinics (Sao Paulo) 66:189–195. https://doi.org/10.1590/s180759322011000200002CrossRefPubMed

66.

Tiryaki S, Yagmur I, Parlar Y, Ozel K, Akyildiz C, Avanoglu A, Ulman I (2015) Botulinum injection is useless on fibrotic neuropathic bladders. J Pediatr Urol 11:27.e1–4. https://doi.org/10.1016/j.jpurol2014.08.009CrossRefPubMed

67.

Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26:785–793. https://doi.org/10.1016/j.neuro.2005.01.017CrossRefPubMed

68.

Silberstein S (2004) Botulinum neurotoxins: origins and basic mechanisms of action. Pain Pract 4(Suppl 1):S19-26. https://doi.org/10.1111/j.1533-2500.2004.04011.xCrossRefPubMed

69.

Lipham WJ (2004) What is botulinum toxin and how does it works? In: Lipham WJ. Cosmetic and clinical application of Botulinum Toxin. Thorofare: Slack 5–9

70.

Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:644–650. https://doi.org/10.1016/j.eururo.2005.12.010CrossRefPubMed

71.

Hascoet J, Manunta A, Brochard C, Arnaud A, Damphousse M, Menard H, Kerdraon J, Journel H, Bonan I, Odent S, Fremond B, Siproudhis L, Gamé X, Peyronnet B, French Referral Network of Spina Bifida (2017) Outcomes of intradetrusor injections of botulinum toxin in patients with spina bifida: a systematic review. Neurourol Urodyn 36:557–564. https://doi.org/10.1002/nau.23025CrossRefPubMed

72.

US Food and Drug Administration. BOTOX (onabotulinumtoxin A) 2011:1–44. www.accessdata.fda.gov. Accessed 2/21/23

73.

Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C (2011) Efficacy and safety of onabotulinumtoxin A in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 60:742–750. https://doi.org/10.1016/j.eururo.2011.07.002CrossRefPubMed

74.

Ginsberg D, Gousse A, Keppenne V, Sievert KD, Thompson C, Lam W, Brin MF, Jenkins B, Haag-Molkenteller C (2012) Phase 3 efficacy and tolerability study of onabotulinumtoxin A for urinary incontinence from neurogenic detrusor overactivity. J Urol 187:2131–2139. https://doi.org/10.1016/j.juro.2012.01.125CrossRefPubMed

75.

Wu SY, Chang SJ, Yang SS, Hsu CK (2021) Botulinum toxin injection for medically refractory neurogenic bladder in children: a systematic review. Toxins (Basel) 13:447. https://doi.org/10.3390/toxins13070447CrossRefPubMed

76.

Moore DC, Cohn JA, Dmochowski RR (2016) Use of botulinum toxin A in the treatment of lower urinary tract disorders: a review of the literature. Toxins (Basel) 8:88. https://doi.org/10.3390/toxins8040088CrossRefPubMed

77.

Panicker JN, Fowler CJ, Kessler TM (2015) Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol 14:72032. https://doi.org/10.1016/S1474-4422(15)00070-8CrossRef

78.

Stein R, Schröder A, Thüroff JW (2012) Bladder augmentation and urinary diversion in patients with neurogenic bladder: surgical considerations. J Pediatr Urol 8:153–161. https://doi.org/10.1016/j.jpurol.2011.11.014CrossRefPubMed

79.

McDougal WS (1998) Use of intestinal segments and urinary diversion. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell’s urology, 7th edn. Philadelphia: Saunders. 3121e61

80.

Steiner MS, Morton RA (1991) Nutritional and gastrointestinal complications of the use of bowel segments in the lower urinary tract. Urol Clin North Am 18:743–754CrossRefPubMed

81.

Tanrikut C, McDougal WS (2004) Acid-base and electrolyte disorders after urinary diversion. World J Urol 22:168–171. https://doi.org/10.1007/s00345-004-0430-zCrossRefPubMed

82.

Gosalbez R Jr, Woodard JR, Broecker BH, Warshaw B (1993) Metabolic complications of the use of stomach for urinary reconstruction. J Urol 150:7102. https://doi.org/10.1016/s0022-5347(17)35594-5CrossRef

83.

Husmann DA, Snodgrass WT, Koyle MA, Furness PD 3rd, Kropp BP, Cheng EY, Kaplan WE, Kramer SA (2004) Ureterocystoplasty: indications for a successful augmentation. J Urol 171:376–380. https://doi.org/10.1097/01.ju.0000100800.69333.4d.Erratum.In:JUrol171:1247CrossRefPubMed

84.

Barbosa LL, Liguori R, Ottoni SL, Barroso U Jr, Ortiz V, Macedo A Jr (2009) Is continent urinary diversion feasible in children under five years of age? Int Braz J Urol 35:459–466. https://doi.org/10.1590/s1677-55382009000400010CrossRefPubMed

85.

Stein R, Wiesner C, Beetz R, Pfitzenmeier J, Schwarz M, Thüroff JW (2005) Urinary diversion in children and adolescents with neurogenic bladder: the Mainz experience. Part II: Continent cutaneous diversion using the Mainz pouch I. Pediatr Nephrol 20:926–931. https://doi.org/10.1007/s00467-005-1848-2CrossRefPubMed

86.

Stein R, Zahn K, Huck N (2019) Current indications and techniques for the use of bowel segments in pediatric urinary tract reconstruction. Front Pediatr 7:236. https://doi.org/10.3389/fped.2019.00236CrossRefPubMedPubMedCentral

87.

Stein R, Schröder A, Beetz R, Ermert A, Filipas D, Fisch M, Goepel M, Körner I, Schönberger B, Sparwasser C, Stöhrer M, Thüroff JW (2007) Urologischer Erkrankungen bei Patienten mit Meningomyelozele. Diagnostik und Management [Urological problems in patients with meningomyelocele. Diagnostic studies and management]. Urologe A 46:1620–1642. https://doi.org/10.1007/s00120-007-1522-3CrossRefPubMed

88.

Stein R, Wessel L, Michel MS (2016) Blasen augmentation und -ersatz bei Kindern und Jugendlichen [Bladder augmentation and urinary diversion in children and adolescents]. Urologe A 55:44–52. https://doi.org/10.1007/s00120-015-0006-0CrossRefPubMed

89.

Mandell J, Bauer SB, Colodny AH, Retik AB (1981) Cutaneous vesicostomy in infancy. J Urol 126:92–93. https://doi.org/10.1016/s0022-5347(17)54396-7CrossRefPubMed

90.

Kryger JV, González R, Barthold JS (2000) Surgical management of urinary incontinence in children with neurogenic sphincteric incompetence. J Urol 163:25663CrossRef

91.

Castellan M, Gosalbez R, Labbie A, Ibrahim E, Disandro M (2005) Bladder neck sling for treatment of neurogenic incontinence in children with augmentation cystoplasty: long-term follow up. J Urol 173:2128–2131; discussion 2131. https://doi.org/10.1097/01.ju.0000157688.41223.d2

92.

Chrzan R, Dik P, Klijn AJ, de Jong TP (2009) Sling suspension of the bladder neck for pediatric urinary incontinence. J Pediatr Urol 5:82–86. https://doi.org/10.1016/j.jpurol.2008.09.002CrossRefPubMed

93.

Gosalbez R, Castellan M (1998) Defining the role of the bladder-neck slingin the surgical treatment of urinary incontinence in children with neurogenic incontinence. World J Urol 16:285–291. https://doi.org/10.1007/s003450050068CrossRefPubMed

94.

Snodgrass WT, Elmore J, Adams R (2007) Bladder neck sling and appendicovesicostomy without augmentation for neurogenic incontinence in children. J Urol 177:1510–1514; discussion 1515. https://doi.org/10.1016/j.juro.2006.11.080

95.

Dave S, Salle JLP (2008) Current status of bladder neck reconstruction. Curr Opin Urol 18:419424. https://doi.org/10.1097/mou.0b013e328302edd5CrossRef

96.

De Troyer B, Van Laecke E, Groen LA, Everaert K, Hoebeke P (2011) A comparative study between continent diversion and bladder neck closure versus continent diversion and bladder neck reconstruction in children. J Pediatr Urol 7:209–212. https://doi.org/10.1016/j.jpurol.2010.03.011CrossRefPubMed

97.

Bergman J, Lerman SE, Kristo B, Chen A, Boechat MI, Churchill B (2006) Outcomes of bladder neck closure for intractable urinary incontinence inpatients with neurogenic bladders. J Pediatr Urol 2:528–533. https://doi.org/10.1016/j.jpurol.2005.12.001CrossRefPubMed

98.

Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum S (2010) Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord 48:718–733. https://doi.org/10.1038/sc.2010.14CrossRefPubMedPubMedCentral

99.

Beierwaltes P, Church P, Gordon T, Ambartsumyan L (2020) Bowel function and care: guidelines for the care of people with spina bifida. J Pediatr Rehabil Med 13:491–498. https://doi.org/10.3233/PRM-200724CrossRefPubMedPubMedCentral

100.

Newman DK, Willson MM (2011) Review of intermittent catheterization and current best practices. Urol Nurs 31:12–28,48; quiz 29

101.

The Harriet Lane Handbook: The Johns Hopkins Hospital Johns Hopkins Hospital Keith K, McDaniel L, Molloy M, Elsevier, 2020 ISSN 13 978- 0323674072

102.

Blencowe H, Kancherla V, Moorthie S, Darlison MW, Modell B (2018) Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann N Y Acad Sci 1414:31–46. https://doi.org/10.1111/nyas.13548CrossRefPubMed

103.

Kancherla V, Chadha M, Rowe L, Thompson A, Jain S, Walters D, Martinez H (2021) Reducing the burden of anemia and neural tube defects in low- and middle-income countries: an analysis to identify countries with an immediate potential to benefit from large-scale mandatory fortification of wheat flour and rice. Nutrients 13:244. https://doi.org/10.3390/nu13010244CrossRefPubMedPubMedCentral

104.

Tong H, Walker N (2021) Current levels of coverage of iron and folic acid fortification are insufficient to meet the recommended intake for women of reproductive age in low- and middle-income countries. J Glob Health 11:18002. https://doi.org/10.7189/jogh.11.18002CrossRefPubMedPubMedCentral

105.

Gashaw A, Shine S, Yimer O, Wodaje M (2021) Risk factors associated to neural tube defects among mothers who gave birth in North Shoa Zone Hospitals, Amhara Region, Ethiopia 2020: Case control study. PLoS One 16:e0250719. https://doi.org/10.1371/journal.pone.0250719CrossRefPubMedPubMedCentral

106.

Sims-Williams HJ, Sims-Williams HP, Kabachelor EM, Fotheringham J, Warf BC (2017) Ten-year survival of Ugandan infants after myelomeningocele closure. J Neurosurg Pediatr 19:70–76. https://doi.org/10.3171/2016.7.PEDS16296CrossRefPubMed

107.

Xu LW, Vaca SD, He JQ, Nalwanga J, Muhumuza C, Kiryabwire J, Ssenyonjo H, Mukasa J, Muhumuza M, Grant G (2018) Neural tube defects in Uganda: follow-up outcomes from a national referral hospital. Neurosurg Focus 45:E9. https://doi.org/10.3171/2018.7.FOCUS18280CrossRefPubMed

108.

Shehu BB, Ameh EA, Ismail NJ (2000) Spina bifida cystica: selective management in Zaria, Nigeria. Ann Trop Paediatr 20:239–242. https://doi.org/10.1080/02724936.2000.11748142CrossRefPubMed

109.

Ulsenheimer MM, Antoniuk SA, Santos LH, Ceccatto MP, Silveira AE, Ruiz AP, Egger P, Bruck I (2004) Myelomeningocele: a Brazilian University Hospital experience. Arq Neuropsiquiatr 62:963–968. https://doi.org/10.1590/s0004-282x2004000600006CrossRefPubMed

110.

Yadav H, Shah D, Sayed S, Horton S, Schroeder LF (2021) Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys. Lancet Glob Health 9:e1553–e1560. https://doi.org/10.1016/S2214109X(21)00442-3CrossRefPubMedPubMedCentral

111.

Liptak GS, Robinson LM, Davidson PW, Dziorny A, Lavalley R, Flaherty MG, Dosa NP (2016) Life course health and healthcare utilization among adults with spina bifida. Dev Med Child Neurol 58:714–720. https://doi.org/10.1111/dmcn.12952CrossRefPubMed

112.

McDonnell GV, McCann JP (2000) Issues of medical management in adults with spina bifida. Childs Nerv Syst 16:222–227. https://doi.org/10.1007/s003810050502CrossRefPubMed

113.

Dicianno BE, Wilson R (2010) Hospitalizations of adults with spina bifida and congenital spinal cord anomalies. Arch Phys Med Rehabil 91:529–535CrossRefPubMedPubMedCentral

114.

Piatt JH Jr (2016) Adults with myelomeningocele and other forms of spinaldysraphism: hospital care in the United States since the turn of the millennium. J Neurosurg Spine 25:69–77. https://doi.org/10.3171/2015.9.SPINE15771CrossRefPubMed

115.

Dicianno BE, Sherman A, Roehmer C, Zigler CK (2018) Co-morbidities associated with early mortality in adults with spina bifida. Am J Phys Med Rehabil 97:861–865. https://doi.org/10.1097/PHM.0000000000000964CrossRefPubMed

116.

Dicianno BE, Kurowski BG, Yang JMJ, Chancellor MB, Bejjani GK, Fairman AD, Lewis N, Sotirake J (2008) Rehabilitation and medical management of the adult with spina bifida. Am J Phys Med Rehabil 87:1027–1050. https://doi.org/10.1097/PHM.0b013e31818de070CrossRefPubMed

117.

Hunt GM (1990) Open spina bifida: outcome for a complete cohort treated unselectively and followed into adulthood. Dev Med Child Neurol 32:108–118. https://doi.org/10.1111/j.1469-8749.1990.tb16910.xCrossRefPubMed

118.

Gatti C, Del Rossi C, Ferrari A, Casolari E, Casadio G, Scire G (2009) Predictors of successful sexual partnering of adults with spina bifida. J Urol 182(4 Suppl):1911–1916. https://doi.org/10.1016/j.juro.2009.02.065CrossRefPubMed

119.

Thibadeau JK, Ward EA, Soe MM, Liu T, Swanson M, Sawin KJ, Freeman KA, Castillo H, Rauen K, Schechter MS (2013) Testing the feasibility of a National Spina Bifida Patient Registry. Birth Defects Res A Clin Mol Teratol 97:36–41. https://doi.org/10.1002/bdra.23094CrossRefPubMed

120.

Sawin KJ, Liu T, Ward E, Thibadeau J, Schechter MS, Soe MM, Walker W; NSBPR Coordinating Committee (2015) The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr 166:444–450.e1. https://doi.org/10.1016/j.jpeds.2014.09.039. Available at https://www.cdc.gov/ncbddd/spinabifida/nsbprregistry.html Accessed 6/8/23

121.

Wiener JS, Suson KD, Castillo J, Routh JC, Tanaka S, Liu T, Ward E, Thibadeau J, Joseph D, National Spina Bifida Patient Registry (2017) Bowel management and continence in adults with spina bifida: results from the National Spina Bifida Patient Registry 2009–15. J Pediatr Rehabil Med 10:335–343. https://doi.org/10.3233/PRM-170466CrossRefPubMedPubMedCentral

122.

Liu T, Ouyang L, Thibadeau J, Wiener JS, Routh JC, Castillo H, Castillo J, Freeman KA, Sawin KJ, Smith K, Van Speybroeck A, Valdez R (2018) Longitudinal study of bladder continence in patients with spina bifida in the National Spina Bifida Patient Registry. J Urol 199:837–843. https://doi.org/10.1016/j.juro.2017.11.048CrossRefPubMed

123.

Alabi NB, Thibadeau J, Wiener JS, Conklin MJ, Dias MS, Sawin KJ, Valdez R (2018) Surgeries and health outcomes among patients with spina bifida. Pediatrics 142:e20173730. https://doi.org/10.1542/peds.2017-3730CrossRefPubMed

124.

Oakeshott P, Poulton A, Hunt GM, Reid F (2019) Walking and living independently with spina bifida: a 50-year prospective cohort study. Dev Med Child Neurol 61:1202–1207. https://doi.org/10.1111/dmcn.14168CrossRefPubMedPubMedCentral

125.

Grimsby GM, Burgess R, Culver S, Schlomer BJ, Jacobs MA (2016) Barriers to transition in young adults with neurogenic bladder. J Pediatr Urol 12:258.e1–5. https://doi.org/10.1016/j.jpurol.2016.04.015CrossRefPubMed

126.

Skokan A, Kovell RC (2018) Advances and challenges in transitional urology: caring for adolescents and young adults with lifelong complex genitourinary conditions. Curr Urol Rep 19:26. https://doi.org/10.1007/s11934-018-0774-3CrossRefPubMed

127.

Woodhouse CR (2001) The fate of the abnormal bladder in adolescence. J Urol 166:2396–2400CrossRefPubMed

128.

The Transition Readiness Assessment Questionnaire (TRAQ) http://hscj.ufl.edu/jaxhats/traq/ Accessed 6/8/2023

129.

Johnson K, Rocque B, Hopson B, Barnes K, Omoike OE, Wood D (2019) The reliability and validity of a newly developed spina bifida-specific Transition Readiness Assessment Questionnaire: Transition Readiness Assessment Questionnaire supplement (TRAQ-SB). J Pediatr Rehabil Med 12:415–422. https://doi.org/10.3233/PRM180599CrossRefPubMed

130.

Starowicz J, Cassidy C, Brunton L (2021) Health concerns of adolescents and adults with spina bifida. Front Neurol 12:745814. https://doi.org/10.3389/fneur.2021.745814CrossRefPubMedPubMedCentral

131.

Rague JT, Kim S, Hirsch JA, Meyer T, Rosoklija I, Larson JE, Swaroop VT, Bowman RM, Bowen DK, Cheng EY, Gordon EJ, Chu DI, Isakova T, Yerkes EB, Chu DI (2021) Assessment of health literacy and self-reported readiness for transition to adult care among adolescents and young adults with spina bifida. JAMA Netw Open 4:e2127034. https://doi.org/10.1001/jamanetworkopen.2021.27034CrossRefPubMedPubMedCentral

132.

Roth JD, Szymanski KM, Ferguson EJ, Cain MP, Misseri R (2019) Transitioning young adults with neurogenic bladder-are providers asking too much? J Pediatr Urol 15:384.e1-384.e6. https://doi.org/10.1016/j.jpurol.2019.04.013CrossRefPubMed

133.

Thong PL, Wong SW, Abdul Manaf MR, Lee ML, Kanaheswari Y (2019) Health related quality of life in paediatric spina bifida. Med J Malaysia 74:281–287PubMed

134.

Rofail D, Maguire L, Kissner M, Colligs A, Abetz-Webb L (2014) Health-related quality of life is compromised in individuals with spina bifida: results from qualitative and quantitative studies. Eur J Obstet Gynecol Reprod Biol 181:214–222. https://doi.org/10.1016/j.ejogrb.2014.07.048CrossRefPubMed

135.

Sawin KJ, Brei TJ, Houtrow AJ (2020) Quality of life: guidelines for the care of people with spina bifida. J Pediatr Rehabil Med 13:565–582. https://doi.org/10.3233/PRM200732; Spina Bifida Association. Guidelines for the Care of People with Spina Bifida. http://www.spinabifidaassociation.org/guidelines

136.

Dinleyici M, Dağlı FŞ (2018) Evaluation of quality of life of healthy siblings of children with chronic disease. Turk Pediatri Ars 53:205–213. https://doi.org/10.5152/TurkPediatriArs.2018.6778CrossRefPubMedPubMedCentral

137.

Velasco J, Ferraris V, Eymann A, Coccia PA, Ghezzi LR, Sánchez MC, De Cunto CL, D’Agostino D, Ferraris JR (2020) Quality of life among siblings of patients with chronic conditions. Arch Argent Pediatr 118:252–257. https://doi.org/10.5546/aap.2020.eng.252CrossRefPubMed

138.

Flewelling KD, Wengryn DM, Buchanan CL, Beltran GP, Vemulakonda VM, Hecht SL (2022) Unexpected challenges faced by caregivers of children with neurogenic bladder. J Ped Urol 18:e1-502.e9. https://doi.org/10.1016/j.jpurol.2022.06.005CrossRef

139.

Sadighian MJ, Allen IE, Quanstrom K, Breyer BN, Suskind AM, Baradaran N, Copp HL, Hampson LA (2021) Caregiver burden among those caring for patients with spina bifida. Urology 153:339–344. https://doi.org/10.1016/j.urology.2021.03.020CrossRefPubMed

Title: Multidisciplinary management of people with spina bifida across the lifespan
Authors: Vera H. Koch
MarcosTomasin Lopes
Erika Furusawa
Katharinne Vaz
Ubirajara Barroso
Publication date: 28-07-2023
Publisher: Springer Berlin Heidelberg
Keywords: Spina Bifida
Spina Bifida
Published in: Pediatric Nephrology / Issue 3/2024
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-023-06067-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Multidisciplinary management of people with spina bifida across the lifespan

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2024

Potential factors associated with a long-term duration of B-cell depletion after using rituximab in patients with nephrotic syndrome

Serum apolipoproteins (apoA-1, apoB, and apoB/apoA-1 ratio) for early identification of dyslipidemia in children with CKD

Prophylactic bilateral nephrectomy and preemptive kidney transplantation for Denys–Drash syndrome prior to development of kidney failure

Fluid assessment, fluid balance, and fluid overload in sick children: a report from the Pediatric Acute Disease Quality Initiative (ADQI) conference

Urinary excretion of calcium, phosphate, magnesium, and uric acid in healthy infants and young children. Influence of feeding practices in early infancy

Associations between anemia and FGF23 in the CKiD study